Source: International Congress 2018 – CTD-ILD and hypersensitivity pneumonitis:  mechanistic insights and prognostic markers
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. Aouadi (Ariana, Tunisia), N. Ghrairi (Ariana, Tunisia), I. Ben Ali (Ariana, Tunisia), I. Sahnoun (Ariana, Tunisia), S. Maalej (Ariana, Tunisia), S. Yalaoui (Ariana, Tunisia), L. Douik-Elgharbi (Ariana, Tunisia). Antinuclear antibodies in interstitial lung diseases: Prevalence and predictive factors. 2964

Member's Comments

No comment yet.

Related content which might interest you: Clinical and pathological findings of patients with interstitial lung diseases associated with antisynthetase other than Jo-1 antibodies Source: Eur Respir J 2005; 26: Suppl. 49, 541s Year: 2005 Antinuclear antibodies and subclinical interstitial lung disease in community-dwelling adults: the MESA study Source: Eur Respir J, 55 (4) 1902262; 10.1183/13993003.02262-2019 Year: 2020 Interstitial lung disease associated with ANCA positivity: a retrospective analysis Source: International Congress 2019 – Immune-mediated interstitial lung diseases: from bench to bedside Year: 2019 High prevalence of serum IgA antibodies against gliadin in patients with interstitial lung diseases confirmed by immunoblotting Source: Eur Respir J 2003; 22: Suppl. 45, 227s Year: 2003 Occurrence of ANCA positivity in persons with silicosis Source: Eur Respir J 2002; 20: Suppl. 38, 604s Year: 2002 Detection of antineutrophil cytoplasmic antibodies (ANCA) and antinuclear antibodies (ANA) in children and adults with cystic fibrosis (CF) Source: Eur Respir J 2007; 30: Suppl. 51, 648s Year: 2007 Serum anti DFS70 antibody titer and lung functional impairment in patients with interstitial lung disease (ILD) Source: International Congress 2017 – The spectrum of CTDs: from pathogenesis to treatment Year: 2017 Antinuclear antibodies and severe evolution of asthma Source: Annual Congress 2007 - Towards controlling severe asthma Year: 2007 Antinuclear autoantibodies (ANA) and C-reactive protein (CRP) in chronic obstructive pulmonary disease (COPD) Source: International Congress 2015 – Monitoring and phenotyping COPD Year: 2015 Prevalence and clinical significance of auto-antibodies in adults with cystic fibrosis Source: Eur Respir J 2009; 34: 1079-1085 Year: 2009 Utility of myositis related antibodies in interstitial lung disease and suspected autoimmunity. Source: International Congress 2019 – From biomarkers to treatment of immune-mediated interstitial lung disease: what’s new? Year: 2019 Differences between ANCA positive and negative lung fibrosis cases without vasculitis Source: International Congress 2019 – Biomarkers and beyond in idiopathic interstitial pneumonia Year: 2019 Clinical implications of ANCA positivity in idiopathic pulmonary fibrosis patients Source: Breathe, 16 (1) 190321; 10.1183/20734735.0321-2019 Year: 2020 Place of anti-CCP antibodies in respiratory manifestations of rheumatoid disease Source: International Congress 2017 – Novel and old entities Year: 2017 Nine cases of interstitial lung disease associated with anti-CADM140 antibody positive dermatomyositis Source: Annual Congress 2012 - Diffuse parenchymal lung disease: clinical profiles and collagen vascular disease Year: 2012 Cure bronchiectasis associated with anti-neutrophil cytoplasmatic antibodies (ANCA) with immunosuppressive therapy Source: International Congress 2015 – New insights into lung disease pathogenesis Year: 2015 Incidence and predictive factors of lung cancer in patients with idiopathic pulmonary fibrosis Source: ERJ Open Res, 4 (1) 00111-2016; 10.1183/23120541.00111-2016 Year: 2018 ANCA positivity is not associated with rheumatoid factor nor with Caplan´s syndrome in asbestos exposure Source: Eur Respir J 2004; 24: Suppl. 48, 146s Year: 2004 Late Breaking Abstract - Prevalence and clinical significance of antinuclear antibody (ANA) in IPF: analysis from ESTAIR study Source: International Congress 2018 – Clinical news in idiopathic interstitial pneumonias Year: 2018 Pulmonary hypertension in patients with lupus: Prevalence, etiology and risk factors Source: Annual Congress 2012 - Pulmonary circulation: clinical databases and registries Year: 2012